Publication: Growth hormone therapy update in Thailand
Issued Date
1998-03-01
Resource Type
ISSN
03010163
Other identifier(s)
2-s2.0-0031934014
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Hormone Research. Vol.49, No.SUPPL. 1 (1998), 15-20
Suggested Citation
Kitti A. Angsusingha, Suttipong Watcharasindhu, Supawadee Likitmaskul, Chanika Tuchinda Growth hormone therapy update in Thailand. Hormone Research. Vol.49, No.SUPPL. 1 (1998), 15-20. doi:10.1159/000053063 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/18309
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Growth hormone therapy update in Thailand
Other Contributor(s)
Abstract
There were 841 children in Thailand with growth hormone deficiency (GHD) from January 1992 to 1996. Idiopathic isolated GHD was the major diagnosis. Only 40.19% received recombinant DNA human growth hormone (rhGH) treatment. Also reported here is a 1-2 year study of rhGH therapy in 30 GH-deficient children (21 males, 9 females), aged (mean ± SD) 10.41 ± 3.16 years, and bone age 7.37 ± 3.34 years. The height velocity 1 and 2 years post-treatment were 8.17 ± 1.9 and 7.36 ± 2.8 cm/year respectively, which were statistically significant compared to pretreatment values of 3.91 ± 1.09 cm/year. Improved height SDS was observed at the end of each treatment period. Thyroid function and glycosylated hemoglobin tests were normal during the treatment period. There were no reports of side effects.